Why the study?
Does cranial radiotherapy combined with chemotherapy increase the risk of obesity in children treated for acute lymphoblastic leukaemia compared to chemotherapy alone?
Does cranial radiotherapy combined with chemotherapy increase the risk of obesity in children treated for acute lymphoblastic leukaemia compared to chemotherapy alone?
Cranial irradiation is an important factor in the development of obesity, particularly in girls, following treatment for acute lymphoblastic leukaemia.
Answers are grounded in this paper and cite their sources.
Cranial radiotherapy may heighten long-term obesity risk in girls with ALL; leaves open causality and relevance to current regimens.
The frequency and pattern of obesity in survivors of acute lymphoblastic leukaemia (ALL) was examined in a retrospective analysis of height and weight at zero, two, and four years from diagnosis in 40 children (19 boys and 21 girls). The children had been treated according to the Medical Research Council protocols UKALL VIII and X, both of which included cranial radiotherapy at a dose of 1800 cGy. Body mass index (BMI), determined as weight/height, was used as a measure of fatness. The BMI Z scores were calculated for each patient from standard tables. The ALL group was compared with a control group of 18 age matched children who had received chemotherapy but no radiotherapy. Changes in BMI between diagnosis and two and four years later were analysed by paired t tests. Mean BMI Z scores at diagnosis were similar between ALL boys, ALL girls, and the control group. Two years after diagnosis the ALL group, particularly the girls, showed a significant increase in BMI. By four years BMI had decreased slightly in the ALL boys, but had increased still further in the ALL girls with 57% having BMI Z scores greater than 2. In the control group BMI increased, but not significantly, at two and four years. It is concluded that the obesity seen in patients treated for ALL is more pronounced in girls than boys, and that cranial irradiation is an important factor.
No takes yet. Share an insight, caveat, or question.
Odame et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: